IIM patients were assigned to either an MDA5+ DM group (34.5% males, mean age 53 ± 10 years) or an MDA5− IIM group (31.5% males, mean age 51 ± 13 years) based on anti-MDA5 antibody results. Here, IFIH1 is linked to dermatomyositis.